Pharmaceutical Preparations · DE · CIK 1034842
Develops and provides novel therapies for hematologic disorders and cancer by targeting critical disease signaling pathways
Comparable business profile · signals at a glance
In the 90 days to Feb 20, 2026: 1 sold $145K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 20, 2026 | Moos Walter HDirector | Sell | 4,000 | $36.36 | $145K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.